Cellromax Science Co

Cellromax Science Co Operating Cash Flow

The Operating Cash Flow of Cellromax Science Co (471820.KQ) as of Nov 7, 2026 is 1.79 B KRW. In the previous year, Operating Cash Flow was 6.29 B KRW — a change of -71.64% (lower).

Operating Cash Flow

1.79 BKRW

YoY

-71.64%

Last updated:

Operating Cash Flow of Cellromax Science Co is 2025 1.79 B KRW. Operating Cash Flow of Cellromax Science Co was 2024 6.29 B KRW. It decreases by -71.64% lower compared to the previous year.

The Cellromax Science Co Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2022
5.52 B KRW
Jan 1, 2023
5.07 B KRW
Jan 1, 2024
6.29 B KRW
Jan 1, 2025
1.79 B KRW
The Cellromax Science Co Operating Cash Flow history
YEAROperating Cash FlowYoY
1.79 BKRW-71.64%
6.29 BKRW+24.25%
5.07 BKRW-8.25%
5.52 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cellromax Science Co Stock analysis

What does Cellromax Science Co do? Cellromax Science Co Ltd generates revenue through the development and distribution of health functional foods, functional cosmetics, and general medicines. The company's primary brand, 'Cellromax,' targets consumers seeking health and wellness solutions. Its products are sold to customers interested in health-focused lifestyle choices, including those purchasing functional foods and cosmetics for daily use. The firm operates within the health and wellness sector, focusing on product innovation and consumer demand for natural health solutions. The company's business model centers around its brand 'Cellromax,' which is used across its health functional food and cosmetic product lines. Revenue is derived from direct sales of these branded products to end consumers. The firm's focus on functional foods and cosmetics positions it within the health and wellness market segment, catering to individuals prioritizing health maintenance and beauty enhancement through scientifically backed products. Cellromax Science Co Ltd's product portfolio includes health functional foods, functional cosmetics, and general medicines. The company distributes these items through retail channels to consumers seeking health and beauty solutions. Its brands, particularly 'Cellromax,' drive customer engagement and sales, with the company emphasizing product quality and scientific validation to attract health-conscious buyers in the Korean market. Cellromax Science Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cellromax Science Co stock

Operating Cash Flow of Cellromax Science Co is 1.79 B KRW in 2025.

Operating Cash Flow of Cellromax Science Co changed from 6.29 B KRW to 1.79 B KRW, representing a -71.64% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Cellromax Science Co since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Cellromax Science Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Cellromax Science Co

All Key Metrics — Cellromax Science Co